ATP5MC1P7

Across TCGA pan-cancer cohorts, ATP5MC1P7 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated ATP5MC1P7 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ATP5MC1P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ATP5MC1P7 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

KIRC, UVM, and KIRP are the cancer types where ATP5MC1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.536	0.676	<.001	131	view →
UVM	DFS	Tertile	All	0.180	0.753	.005	54	view →
KIRP	OS	Tertile	All	0.877	0.973	<.001	46	view →
ACC	OS	Tertile	IV	0.145	0.715	<.001	33	view →
LAML	DFS	Median	All	0.268	0.452	.019	24	view →
LGG	DFS	Tertile	All	0.312	0.432	.001	21	view →
TGCT	OS	Tertile	II,III,IV	0.670	1.000	.005	18	view →
HNSC	OS	Tertile	All	0.453	0.311	.013	14	view →
SKCM	DFS	Quartile	All	0.134	0.226	.008	10	view →
MESO	OS	Tertile	IV	0.266	0.608	.044	9	view →
ESCA	DFS	Median	IV	0.213	0.626	.026	7	view →
DLBC	DFS	Tertile	IV	0.161	0.796	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

ATP5MC1P7–KIRC (OS)

Open the KIRC breakdown →